Marker Therapeutics, Inc. (MRKR)
1.28
+0.02
(+1.59%)
USD |
NASDAQ |
Dec 19, 16:00
1.26
-0.02
(-1.56%)
Pre-Market: 20:00
Marker Therapeutics Market Cap: 21.34M for Dec. 19, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics, Inc. | 4.660B |
| Neurocrine Biosciences, Inc. | 14.46B |
| AIM ImmunoTech, Inc. | 1.085M |
| Protalix Biotherapeutics, Inc. | 139.13M |
| Armata Pharmaceuticals, Inc. | 223.79M |
Market Cap Related Metrics
| PS Ratio | 3.471 |
| PEG Ratio | -0.0762 |
| Price to Book Value | 1.161 |
| Price | 1.28 |
| Earnings Yield | -96.02% |
| PEGY Ratio | -0.0762 |